DDR1 and neoplasm: Given the dual roles of DDR1 in tumor progression—where its extracellular non-enzymatic domain exerts immunosuppressive effects, and its intracellular enzymatic domain promotes tumor proliferation—inducing DDR1 degradation may represent a more effective strategy to overcome the limited accessibility of DDR1 inhibitors.